{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=28", "query": { "condition": "Multi Center", "page": 28 }, "page_size": 10 }, "pagination": { "page": 28, "page_size": 10, "total_count": 6600, "total_pages": 660, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=29&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Multi+Center&page=27&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-08T03:25:24.154Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03005717", "title": "Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Submental Fat" ], "interventions": [ { "name": "LIPO-202", "type": "DRUG" }, { "name": "Placebo for LIPO-202", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neothetics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 162, "start_date": "2016-12-22", "completion_date": "2017-06-02", "has_results": false, "last_update_posted_date": "2017-10-20", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 11, "location_summary": "Beverly Hills, California • Manhattan Beach, California • Greenwood Village, Colorado + 8 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Manhattan Beach", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Warren", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03005717" }, { "nct_id": "NCT01176240", "title": "A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Orthostatic Hypotension", "Parkinson's Disease" ], "interventions": [ { "name": "Droxidopa", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Chelsea Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 225, "start_date": "2010-06", "completion_date": "2012-11", "has_results": true, "last_update_posted_date": "2014-05-20", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 60, "location_summary": "Alabaster, Alabama • Gilbert, Arizona • Phoenix, Arizona + 53 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01176240" }, { "nct_id": "NCT04164550", "title": "Interpolated Flap Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Skin Cancer, Non-Melanoma", "Skin Cancer Melanoma", "Mohs Micrographic Surgery" ], "interventions": [], "intervention_types": [], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 170, "start_date": "2018-04-18", "completion_date": "2020-08-01", "has_results": false, "last_update_posted_date": "2020-08-05", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04164550" }, { "nct_id": "NCT02570308", "title": "A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Uveal Melanoma" ], "interventions": [ { "name": "IMCgp100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Immunocore Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 146, "start_date": "2016-02-29", "completion_date": "2022-10-17", "has_results": true, "last_update_posted_date": "2023-03-21", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 17, "location_summary": "La Jolla, California • Los Angeles, California • San Francisco, California + 13 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02570308" }, { "nct_id": "NCT05669989", "title": "International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plasma Cell Myeloma" ], "interventions": [ { "name": "Isatuximab intravenous (IV)", "type": "DRUG" }, { "name": "Cemiplimab (SAR439684)", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Isatuximab subcutaneous (SC)", "type": "DRUG" }, { "name": "Carfilzomib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2023-04-05", "completion_date": "2028-11-30", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05669989" }, { "nct_id": "NCT00308308", "title": "Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes, Type I" ], "interventions": [ { "name": "Technosphere Insulin", "type": "DRUG" }, { "name": "Active comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mannkind Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 589, "start_date": "2006-02", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2014-10-16", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 61, "location_summary": "Mobile, Alabama • Chandler, Arizona • Chula Vista, California + 48 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Foothill Ranch", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308308" }, { "nct_id": "NCT00772785", "title": "Study of Probuphine in Patients With Opioid Dependence", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Opioid Dependency" ], "interventions": [ { "name": "Probuphine (buprenorphine implant)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Titan Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 16, "start_date": "2008-09", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2018-12-31", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 1, "location_summary": "North Miami, Florida", "locations": [ { "city": "North Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00772785" }, { "nct_id": "NCT04705168", "title": "Study of the Nevisense Device to Assess Atypical Skin Lesions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nevus", "Multiple Nevi", "Large Acquired Nevi", "Skin Lesion" ], "interventions": [ { "name": "Nevisense electrical impedance spectroscopy", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 40, "start_date": "2021-01-08", "completion_date": "2025-11-18", "has_results": false, "last_update_posted_date": "2025-11-20", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 3, "location_summary": "Basking Ridge, New Jersey • Harrison, New York • New York, New York", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04705168" }, { "nct_id": "NCT05438303", "title": "Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "AZD9833", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Dabigatran Etexilate", "type": "DRUG" }, { "name": "Celecoxib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "50 Years to 70 Years · Female only" }, "enrollment_count": 59, "start_date": "2022-06-13", "completion_date": "2022-12-13", "has_results": false, "last_update_posted_date": "2023-01-12", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 2, "location_summary": "Long Beach, California • Berlin, New Jersey", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Berlin", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05438303" }, { "nct_id": "NCT06063850", "title": "AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Mesial Temporal Lobe Epilepsy" ], "interventions": [ { "name": "AAV9-hSyn1-miGRIK2", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "UniQure Biopharma B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 12, "start_date": "2024-06-12", "completion_date": "2031-12", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-11-08T03:25:24.154Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Palo Alto, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06063850" } ] }